Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Conference on Diabetes and Cardiovascular Diseases (ICDCD 2026) bringing together researchers, healthcare professionals, academics, and other stakeholders in diabetes and cardiovascular medicine. The conference provides opportunities for research presentations, scientific discussion, professional networking, collaboration, and scholarly publication.
The International Conference on Diabetes and Cardiovascular Diseases (ICDCD 2026) is an international scientific conference organized by the Society for Engineering Research (SFER) and scheduled for 23 November 2026 in Doha, Qatar. The conference focuses on the interconnected fields of diabetes and cardiovascular diseases and provides a platform for researchers, healthcare professionals, academics, practitioners, research scholars, and other stakeholders to exchange scientific knowledge and present research findings. Diabetes and cardiovascular diseases are closely connected areas of healthcare, with metabolic disorders and cardiovascular risk frequently requiring coordinated approaches to prevention, diagnosis, treatment, and long-term management. By bringing together participants from different healthcare and research disciplines, the conference provides an environment for discussing developments in diabetes care, cardiovascular medicine, metabolic health, and related biomedical research. A central component of ICDCD 2026 is the presentation of research. Participants can present their work through oral and poster presentations, providing opportunities to communicate research findings, methodologies, observations, and emerging ideas to an international audience. These presentations can also encourage discussion and exchange of perspectives between researchers and professionals working in different areas of diabetes and cardiovascular health. The conference is particularly relevant to cardiologists, endocrinologists, diabetologists, internists, biomedical researchers, healthcare professionals, public-health specialists, academics, and postgraduate researchers. Participants can explore research and professional perspectives concerning the relationship between metabolic disorders and cardiovascular health, as well as developments relevant to prevention, clinical management, and patient care. Beyond formal presentations, the conference provides opportunities for professional networking and international collaboration. Participants can interact with researchers and healthcare professionals from different institutions and countries, exchange experiences, identify shared research interests, and establish connections that may contribute to future academic and professional projects. Research dissemination is another important component of the conference format. SFER's conference framework accommodates different types of scholarly contributions, including original research papers, review papers, surveys, case studies, technical reports, and other research-related works. Eligible research contributions may provide participants with opportunities to share their findings with a broader academic audience. The conference also includes recognition of research contributions through Best Paper Awards. Such recognition provides an opportunity to highlight selected research work presented during the conference and encourages participants to contribute original and relevant research to the scientific programme. Overall, ICDCD 2026 provides an international forum for scientific exchange at the intersection of diabetes and cardiovascular diseases. Through research presentations, academic discussion, professional networking, collaboration, and research dissemination, the conference offers researchers and healthcare professionals an opportunity to engage with developments in these closely connected areas of medicine and biomedical research.
Latest guidelines and therapeutic approaches for managing different types of diabetes.
Strategies for preventing and treating microvascular and macrovascular complications.
Recent advancements in the diagnosis and treatment of major cardiovascular conditions.
Evidence-based practices for blood pressure control and risk reduction.
Understanding the pathophysiological links between metabolic disorders and heart disease.
Lifestyle interventions and pharmacological strategies to prevent cardiovascular events in diabetic patients.
Exploring the role of artificial intelligence and data science in predicting and managing chronic diseases.
Bridging the gap between laboratory discoveries and clinical applications.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
| Registration | Category | Valid Until | Price |
|---|---|---|---|
| Student (All Masters/PhDs/Research Scholars/Post Doc.) - Early Bird | Student | Oct 09, 2026 | USD 230 |
| Student (All Masters/PhDs/Research Scholars/Post Doc.) - Regular | Student | Nov 03, 2026 | USD 270 |
| Student (All Masters/PhDs/Research Scholars/Post Doc.) - Video Conference | Student | Nov 03, 2026 | USD 219 |
| Student (All Bachelors) - Early Bird | Student | Oct 09, 2026 | USD 210 |
| Student (All Bachelors) - Regular | Student | Nov 03, 2026 | USD 250 |
| Student (All Bachelors) - Video Conference | Student | Nov 03, 2026 | USD 199 |
| Delegates (Academician/Industrial Professional) - Early Bird | Professional | Oct 09, 2026 | USD 280 |
| Delegates (Academician/Industrial Professional) - Regular | Professional | Nov 03, 2026 | USD 320 |
| Delegates (Academician/Industrial Professional) - Video Conference | Professional | Nov 03, 2026 | USD 269 |
| Listeners - Early Bird | Listener | Oct 09, 2026 | USD 150 |
| Listeners - Regular | Listener | Nov 03, 2026 | USD 200 |
| Listeners - Video Conference | Listener | Nov 03, 2026 | USD 149 |